Evidence map›Paper›PMID 24853429›Full record

ArticleCell death & disease2014

Sulfur dioxide inhibits vascular smooth muscle cell proliferation via suppressing the Erk/MAP kinase pathway mediated by cAMP/PKA signaling.

D Liu, Y Huang, D Bu, A D Liu, L Holmberg, Y Jia, C Tang, J Du, H Jin

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 127 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. PGEThe EMBO journal · 2022
    Article
  10. A Whiff of Sulfur: One Wind a Day Keeps the Doctor Away.Antioxidants (Basel, Switzerland) · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Effect of sulfur dioxide on vascular biology.Histology and histopathology · 2021
    Review
  17. Endogenous SORedox biology · 2021
    Article
  18. Article
  19. Review
  20. Endogenous SOFrontiers in cell and developmental biology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

D LiuDepartment of Pediatrics, Peking University First Hospital, Beijing, People's Republic of China.
Y HuangDepartment of Pediatrics, Peking University First Hospital, Beijing, People's Republic of China.
D BuCentral Laboratory, Peking University First Hospital, Beijing, People's Republic of China.
A D LiuDepartment of Medical and Health Sciences, Linköping University, Linköping, Sweden.
L HolmbergDepartment of Medical and Health Sciences, Linköping University, Linköping, Sweden.
Y JiaCentre of Medical and Health Analysis, Peking University Health Science Center, Beijing, People's Republic of China.
C Tang1] Department of Physiology and Pathophysiology, Peking University Health Science Center, Beijing, People's Republic of China [2] Key Laboratory of Molecular Cardiology, Ministry of Education, Beijing, People's Republic of China.
J Du1] Department of Pediatrics, Peking University First Hospital, Beijing, People's Republic of China [2] Key Laboratory of Molecular Cardiology, Ministry of Education, Beijing, People's Republic of China.
H JinDepartment of Pediatrics, Peking University First Hospital, Beijing, People's Republic of China.
Peking University · CNLinköping University · SEPeking University First Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study was designed to investigate the role of endogenous sulfur dioxide (SO2) in vascular smooth muscle cell (VSMC) proliferation, and explore the possible role of cross-talk between cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) and extracellular signal-regulated kinase (Erk)/mitogen-activated protein kinase (MAPK) pathways in this action. By cell counting, growth curve depict, flow cytometry and bromodeoxyuridine (BrdU) labeling assays, we found that SO2 inhibited VSMC proliferation by preventing cell cycle progression from G1 to S phase and by reducing DNA synthesis. SO2 synthase aspartate aminotransferase (AAT1 and AAT2) overexpression significantly inhibited serum-induced proliferating cell nuclear antigen (PCNA) protein expression in VSMCs, demonstrated by western blot analysis. Moreover, overexpression of AAT1 or AAT2 markedly reduced incorporation of BrdU in serum-treated VSMCs. By contrast, either AAT1 or AAT2 knockdown significantly exacerbated serum-stimulated VSMC proliferation. Thus, both exogenous- and endogenous-derived SO2 suppressed serum-induced VSMC proliferation. However, annexin V-propidium iodide (PI) staining and cell cycle analysis demonstrated that SO2 did not influence VSMC apoptosis in the serum-induced proliferation model. In a platelet-derived growth factor (PDGF)-BB-stimulated VSMC proliferation model, SO2 dephosphorylated the active sites of Erk1/2, MAPK kinase 1/2 and RAF proto-oncogene serine/threonine-protein kinase (c-Raf) induced by PDGF-BB. However, the inactivation of the three kinases of the Erk/MAPK pathway was not due to the separate interferences on them by SO2 simultaneously, but a consequence of the influence on the upstream activity of the c-Raf molecule. Hence, we examined the cAMP/PKA pathway, which could inhibit Erk/MAPK transduction in VSMCs. The results showed that SO2 could stimulate the cAMP/PKA pathway to block c-Raf activation, whereas the Ser259 site on c-Raf had an important role in SO2-induced suppression of Erk/MAPK pathway. The present study firstly demonstrated that SO2 exerted a negative regulation of VSMC proliferation via suppressing the Erk/MAPK pathway mediated by cAMP/PKA signaling.

Indexed as

AnimalsAspartate AminotransferasesBecaplerminCell ProliferationCyclic AMPCyclic AMP-Dependent Protein KinasesDose-Response Relationship, DrugDown-RegulationEnzyme ActivationExtracellular Signal-Regulated MAP KinasesG1 Phase Cell Cycle CheckpointsHEK293 CellsHumansMAP Kinase Kinase 1MAP Kinase Kinase KinasesMuscle, Smooth, VascularAspartate AminotransferasesBecaplerminCyclic AMPCyclic AMP-Dependent Protein KinasesExtracellular Signal-Regulated MAP KinasesMAP Kinase Kinase 1MAP Kinase Kinase KinasesMAS1 protein, humanProto-Oncogene MasProto-Oncogene Proteins c-rafProto-Oncogene Proteins c-sisRaf1 protein, ratSulfur Dioxide

Identifiers

PMID24853429
PMCPMC4047873
OpenAlexW2063420743

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.